COVID-19 studies:  C19 studies: C19:  IvermectinIVM Vitamin DV.D HC QHC Q Vitamin CV.C ZincZn PVP-IPVP-I FLVFLV REGNR2 LY-CoVLY RemdesivirRMD
HCQ safety analysis
1/4 Safety
Gautret et al., International Journal of Antimicrobial Agents, doi:10.1016/j.ijantimicag.2020.106236 (Peer Reviewed) (not included in the study count)
Safety profile of hydroxychloroquine and azithromycin combined treatment in COVID-19 patients
Source   PDF   Share   Tweet
Report on the safety of HCQ+AZ with 3,737 COVID-19 patients. 138 had contraindications and treatment was discontinued in 12 cases due to QTc prolongation. There were no cases of torsade de pointe or sudden death.

Gautret et al., 1/4/2021, peer-reviewed, 4 authors.
Details of all 260 studies    Meta analysis
Please send us corrections, updates, or comments.
Submit